Clinical Trials
18
Trial Phases
4 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (17 trials with phase data)• Click on a phase to view related trials
PG2 Injection for the Treatment of moderate-to Severe Fatigue in Breast Cancer Patients
- Conditions
- Cancer-related Fatigue
- Interventions
- Drug: PG2 Lyo. Injection 500mgDrug: Placebo 0.9% normal saline
- First Posted Date
- 2022-06-30
- Last Posted Date
- 2025-06-05
- Lead Sponsor
- PhytoHealth Corporation
- Target Recruit Count
- 36
- Registration Number
- NCT05440227
- Locations
- 🇨🇳
National Taiwan University Hospital, Taipei, Taiwan
PG2 Concurrent With Chemoradiation for Locally Advanced Esophageal Cancer
- Conditions
- Cancer-related FatigueSurvivalTumor, Esophageal
- Interventions
- Drug: Astragalus Polysaccharides 500 mg
- First Posted Date
- 2018-08-02
- Last Posted Date
- 2025-06-04
- Lead Sponsor
- PhytoHealth Corporation
- Target Recruit Count
- 48
- Registration Number
- NCT03611712
- Locations
- 🇨🇳
Mackay Memorial Hospital, Taipei, Taiwan
🇨🇳Tri-Service General Hospital, Taipei, Taiwan
🇨🇳Far Eastern Memorial Hospital, Taipei, Taiwan
PG2 Treatment Among Stage II/III Breast Cancer Patients Receiving Adjuvant Chemotherapy
- Conditions
- Neutropenia, MalignantCancer-related Fatigue
- Interventions
- Drug: PlaceboDrug: Astragalus polysaccharides 500 mgProcedure: EC Chemotherapy
- First Posted Date
- 2017-10-19
- Last Posted Date
- 2025-06-04
- Lead Sponsor
- PhytoHealth Corporation
- Target Recruit Count
- 67
- Registration Number
- NCT03314805
- Locations
- 🇨🇳
Chang Gung Memorial Hospital, Lovers Lake branch, Keelung, Taiwan
🇨🇳E-Da Cancer Hospital, Kaohsiung City, Taiwan
🇨🇳Chang Gung Memorial Hospital, Kaohsiung Branch, Kaohsiung City, Taiwan
Study of PHN131 in Patients After Surgery
- Conditions
- Analgesia Disorder
- Interventions
- Drug: Placebo soft capsulesDrug: PHN131 soft capsule with Nalbuphine HCl 60 mg/capDrug: Dicofenac
- First Posted Date
- 2014-07-17
- Last Posted Date
- 2025-06-05
- Lead Sponsor
- PhytoHealth Corporation
- Target Recruit Count
- 106
- Registration Number
- NCT02193620
- Locations
- 🇨🇳
General Clinical Research Center, Tri-service General Hospital, Taipei city, Taiwan
Study of PHN131 in Healthy Volunteers
- Conditions
- Analgesia Disorder
- First Posted Date
- 2014-07-16
- Last Posted Date
- 2025-06-06
- Lead Sponsor
- PhytoHealth Corporation
- Target Recruit Count
- 16
- Registration Number
- NCT02192151
- Locations
- 🇨🇳
General Clinical Research Center, Tri-service General Hospital, Taipei, Taiwan
- Prev
- 1
- 2
- 3
- 4
- Next
News
PG2® Plus Chemoradiotherapy Improves Survival in Esophageal Cancer Patients
A clinical study by PhytoHealth Corporation shows that Astragalus Polysaccharides (PG2®) combined with chemoradiotherapy (CCRT) significantly improves survival in advanced esophageal cancer patients.